CD44 and hepatocellular carcinoma: 1A and 1B, GLA decreased the expressions of these genes in HepG2 cells in a dose-dependent manner; meanwhile, the decreased expressions of CD44 and EpCAM were also observed in another two HCC cells (Huh-7 and MHCC97H).